Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772380 · ClinicalTrials.gov registry record · NA
Acute Study to Collect Electrical Signals From the Heart Using a Special Lead
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT02772380 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 87 participants.
The verdict
NCT02772380, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The main purpose of this clinical study is to collect electrograms from an investigational lead placed in an extravascular space, for development of a future Implantable Cardioverter Defibrillator (ICD) system.
Interventions
- DEVICE Defibrillation following induction of VT/VF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02772380
The ClinicalTrials.gov registry entry for NCT02772380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Defibrillation following induction of VT/VF is the first listed.
NCT02772380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02772380 about?
NCT02772380 is a clinical study titled "Acute Study to Collect Electrical Signals From the Heart Using a Special Lead". The main purpose of this clinical study is to collect electrograms from an investigational lead placed in an extravascular space, for development of a future Implantable Cardioverter Defibrillator (ICD) system.
What is the current status of trial NCT02772380?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2016-05. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02772380?
The interventions under investigation include: Defibrillation following induction of VT/VF (DEVICE).
Who is sponsoring clinical trial NCT02772380?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.